Atour Lifestyle Holdings Ltd

ATAT

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 193,558Value: $7.6M

**Signal Note: Driehaus Entry into ATAT** This signal is likely a false positive for biotech analysts—Atour Lifestyle Holdings is a Chinese budget hotel operator with no drug pipeline, not a life sciences company. Driehaus's $7.6M position reflects a growth/value play on hospitality real estate, not a biotech catalyst, and should be disregarded for drug development tracking.

More ATAT Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: